Paper40762016
Neoadjuvant immunotherapy for resectable primary liver cancer (Review).
Deng Q and 3 others. Oncol Lett, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Neoadjuvant immunotherapy for resectable primary liver cancer (Review). Papers, record 40762016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40762016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References143
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15221919 | Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. | J Surg Oncol | 2004 | https://conductscience.org/library/papers/15221919 | PubMed |
| 2 | 31358424 | Checkpoint inhibitor-induced liver injury: A novel form of liver disease emerging in the era of cancer immunotherapy. | Semin Diagn Pathol | 2019 | https://conductscience.org/library/papers/31358424 | PubMed |
| 3 | 38954360 | Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristics. | Hepatol Int | 2024 | https://conductscience.org/library/papers/38954360 | PubMed |
| 4 | 31781831 | Immune capacity determines outcome following surgery or trauma: a systematic review and meta-analysis. | Eur J Trauma Emerg Surg | 2020 | https://conductscience.org/library/papers/31781831 | PubMed |
| 5 | 18566595 | How regulatory T cells work. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18566595 | PubMed |
| 6 | 39255928 | Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study. | J Hepatol | 2025 | https://conductscience.org/library/papers/39255928 | PubMed |
| 7 | 27663893 | Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. | Cancer Discov | 2016 | https://conductscience.org/library/papers/27663893 | PubMed |
| 8 | 31065295 | Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective. | Ther Adv Med Oncol | 2019 | https://conductscience.org/library/papers/31065295 | PubMed |
| 9 | 31686845 | Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31686845 | PubMed |
| 10 | 32359091 | Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies. | Int J Cancer | 2020 | https://conductscience.org/library/papers/32359091 | PubMed |
| 11 | 35004667 | Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/35004667 | PubMed |
| 12 | 32951909 | Preoperative immunotherapy for resectable hepatocellular carcinoma: Toward a paradigm shift? | J Hepatol | 2020 | https://conductscience.org/library/papers/32951909 | PubMed |
| 13 | 7672764 | Resection versus resection combined with adjuvant pre- and post-operative chemotherapy--immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. | Hepatogastroenterology | 1995 | https://conductscience.org/library/papers/7672764 | PubMed |
| 14 | 25010665 | Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. | Ann Surg | 2015 | https://conductscience.org/library/papers/25010665 | PubMed |
| 15 | 39527136 | Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/39527136 | PubMed |
| 16 | 34575463 | Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34575463 | PubMed |
| 17 | 31262965 | Electroporation. | Cold Spring Harb Protoc | 2019 | https://conductscience.org/library/papers/31262965 | PubMed |
| 18 | 36727075 | Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36727075 | PubMed |
| 19 | 26826241 | Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1. | J Immunol | 2016 | https://conductscience.org/library/papers/26826241 | PubMed |
| 20 | 28425018 | Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices. | Curr Treat Options Gastroenterol | 2017 | https://conductscience.org/library/papers/28425018 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42645397 | The Evolving Role of Immunotherapy in the Treatment with Curative Purpose of Early, Intermediate and Advanced Stage Hepatocellular Carcinoma. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42645397 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40762016
GET https://conductscience.org/api/papers/v1/40762016/references?page=2